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Esophageal cancer, the sixth most common cause of cancer death, is associated with very poor survival (mortality-to-incidence ratio of 0.88) and was responsible for 500,000 deaths worldwide in 2018 ([@ref1]). In that year, the highest mortality (10.7 deaths per 100,000 person-years) and incidence rates were both reported in eastern Asia. In 2012, 87% of the esophageal cancer cases were esophageal squamous cell carcinoma (ESCC), 79% of which occurred in China, India, and Southeast and Central Asia ([@ref2]).

Gastric atrophy caused by chronic *Helicobacter pylori* infection is already known to be involved in the development of gastric cancer ([@ref3]). Moreover, Ye et al. ([@ref4]) first reported an unexpected association between gastric atrophy and ESCC risk, a result subsequently confirmed by 2 case-control studies based on endoscopy findings in Japan ([@ref5], [@ref6]). One of these also reported a rising risk with increasing severity of the gastric atrophy (histological fundic atrophy and fundic intestinal metaplasia) ([@ref5]). Another retrospective, register-based study of endoscopy findings in Japan reported a higher proportion of gastric atrophy in ESCC patients compared with patients with esophageal adenocarcinoma ([@ref7]).

However, although a cohort study in the Netherlands also observed a positive association between gastric atrophy and the risk for ESCC, they could not confirm that the risk increased with the severity of gastric atrophy ([@ref8]). Therefore, they concluded that a causal relationship seems unlikely and that the association can be explained by confounding factors such as smoking ([@ref8]). Furthermore, a prospective case-cohort study did not find an association between the level of serum pepsinogen, a marker for gastric atrophy, and ESCC in Linxian, China, a high-risk area for this carcinoma ([@ref9]).

Poor oral health has been reported to be an independent risk factor for ESCC in high-risk areas ([@ref10], [@ref11]). In a case-control study on a high-risk population in Iran by Nasrollahzadeh et al. ([@ref12]), they not only once again confirmed the association between gastric atrophy (assessed on the basis of serum pepsinogens) and ESCC but also observed a potential interaction with poor oral health that led to a further increase in the risk. However, that study did not have sufficient statistical power (293 cases and 524 controls), particularly for interaction analysis, and it also had certain limitations in study design (e.g., the utilization of neighborhood controls and individual matching, which might have introduced overmatching bias and hampered appropriate analysis of interaction, respectively). The mechanism underlying the relationship between gastric atrophy and ESCC is still unknown ([@ref13]); it could involve reductions in the number/activity of gastric glands and less acid secretion in the atrophic stomach, which would enable bacterial proliferation ([@ref14]). Carcinogens produced by bacteria, such as nitrosamines and acetaldehyde, might then enter the esophagus through regurgitation and cause esophageal cancer ([@ref15]); nonacidic reflux has also been proposed to be the missing link between gastric atrophy and ESCC ([@ref16]). Moreover, poor oral health, with altered bacterial flora in the oral cavity and additional carcinogens entering the esophagus, might further elevate the risk for ESCC ([@ref10]).

In the light of such inconsistent findings regarding the association between gastric atrophy and ESCC, as well as the earlier lack of sufficient statistical power to examine the possible interaction between gastric atrophy and poor oral health, we designed the present large population-based, case-control study in a high-risk region in China.

METHODS {#sec1}
=======

Subject recruitment {#sec2}
-------------------

The research design and flow of subject recruitment have been described in detail previously ([@ref17]). In brief, we performed a population-based, case-control study from 2010--2014 in Taixing, Jiangsu province, China, where the incidence of ESCC is high ([@ref11]). More than 90% of the esophageal cancer patients in this area are referred to the 4 largest hospitals (the People's Hospital of Taixing, the Second People's Hospital of Taixing, the Third People's Hospital of Taixing, and the Hospital of Traditional Chinese Medicine of Taixing).

Individuals diagnosed by the endoscopy units in these hospitals between October 2010 and September 2013 were invited to participate. This approach was designed to reduce the risk of nondifferential recall bias, given that these patients were unaware of their cancer diagnosis at the time of recruitment and data collection. We complemented this case recruitment with linkage to the local cancer registry during the same period. Altogether, 1,681 suspected cases of esophageal cancer were identified by the hospitals and through linkage to the local cancer registry. On the basis of available sections from formalin-fixed and paraffin-embedded tissue blocks stained with hematoxylin-eosin, a pathologist histopathologically verified 1,499 cases of cancer (78.3% of the total number indicated in the local cancer registry), including 1,418 cases of ESCC and 81 tumors of other types. Here only the cases of ESCC are analyzed ([Figure 1](#f1){ref-type="fig"}).

![Flowchart illustrating the recruitment of cases of esophageal squamous cell carcinoma (ESCC) and control individuals in connection with a population-based, case-control study conducted in Taixing, China, 2010--2014. EC, esophageal cancer; PGI, pepsinogen I; PGII, pepsinogen II.](kwz283f1){#f1}

We utilized the Taixing Total Population Registry to randomly select control individuals who frequency-matched the patients in sex and age (within the same 5-year group) every 12 months. Simultaneously, cases of gastric cancer were enrolled. Because the age distributions for development of these 2 types of cancer are similar, a common set of controls was employed.

In total, 2,699 potential cases of gastroesophageal cancer were identified. Anticipating a moderately high nonresponse rate (20%--30%) among controls, we randomly selected 1.3 controls per case, for a total of 3,501. Of these, 643 were excluded due to death, emigration out of the study area, or inability to contact, leaving 2,858 eligible controls, of whom 2,011 provided informed consent and 1,992 were aged 40--85 years, giving a participation rate of 70.4% (2,011/2,858) ([Figure 1](#f1){ref-type="fig"}).

Quality control {#sec3}
---------------

The inclusion criteria were an age of 40--85 years and residency in Taixing for at least the last 5 years. We attempted to reduce the risk of information bias by tape recording the interviews and assigning each interviewer the same number of cases and controls to balance information misclassification.

To examine the influence of potential selection bias, we compared the age and sex distribution of the enrolled (78.3%) and nonenrolled (21.7%) cases and enrolled (69.7%) and nonenrolled (30.3%) controls and found no statistically significant differences (Web Table 1, available at https://academic.oup.com/aje). We could not assess any potential differences in other demographic, clinical, or social characteristics, because we did not have such information concerning the nonrespondents.

Data collection and assays for biomarkers {#sec4}
-----------------------------------------

The staff involved were specially trained to perform face-to-face interviews using a structured electronic questionnaire, covering factors proposed to be potential confounders in connection with previous studies in this area (demographic characteristics, lifestyle, family structure, and history of cancer).

Our aim was to collect 10-mL blood samples (2 tubes) from all participants, but 208 cases and 14 controls did not have available samples upon analysis. Serum prepared from 1,210 cases and 1,978 controls was stored at −80°C for later determination of pepsinogen I and II (PGI and PGII) concentrations by enzyme-linked immunosorbent assay (Pepsinogen I and II Kits; Biohit Healthcare, Helsinki, Finland) at Qilu Hospital of Shandong University, China. The interassay coefficients of variation were 11.3% and 14.9%, respectively. Immunoglobulin G antibodies directed against *H. pylori* were quantified by immunoblotting (*H. pylori* IgG Antibody Detection Kit; Syno Gene Digital Technology, Taizhou, China).

Statistical analysis {#sec5}
--------------------

Although a low level of serum PGI correlates with gastric fundic atrophy ([@ref20]), there are no generally accepted cutoff values for PGI, PGII, or the PGI:PGII ratio in this connection. On the basis of our previous study of an Asian population ([@ref12]), we chose a serum level of PGI below 55 μg/L (sensitivity 61.9%, specificity 94.8%, positive predictive value 48.1%, negative predictive value 97.2%, and area under the curve 0.78) as the serological definition of this condition. A similar criterion was proposed on the basis of an investigation on a Chinese population ([@ref21]). In addition, we examined potential associations employing other definitions of gastric atrophy ([@ref22]).

The distributions of demographic and pepsinogen values for cases and controls were compared using the Mann-Whitney unpaired test for continuous variables and χ^2^ test or Fisher's exact (observed number \< 5) test for categorical variables (after excluding missing values). We used unconditional logistic regression models to estimate the odds ratios with 95% confidence intervals for association of ESCC with gastric atrophy as indicated by the serum concentration of PGI or PGII or PGI:PGII ratio.

### Model fitting. {#sec6}

Our multivariate analysis involved fitting 3 models. In the first model, we adjusted only for the frequency-matched variables age (continuous) and sex. For the "almost fully adjusting" model, we also adjusted for education (illiteracy, primary school, middle school, high school and above), marital status (unmarried, married, divorced or widowed), occupation (farmer, worker, service/clerk/professional/administrator), family wealth score (quartiles 1--5), body mass index 10 years before (\<18.5, 18.5--23.9, 24.0--27.9, ≥28.0), tea drinking (never/ever), history of esophageal cancer among first-degree relatives (no/yes), cigarette smoking (in pack years: never-smoker, former-smoker, current light smoker (≤18), current medium smoker (19--40), current heavy smoker (\>41)), alcohol consumption in g/day (never drinker, former drinker, current low consumption (≤40), current medium consumption (41--135), current high consumption (\>135)), and *H. pylori* serostatus (negative/positive). The full model also took into account the sum of missing and filled teeth (quartiles: 0, 1--3, 3--11, ≥12) and number of daily toothbrushings (≤1, ≥2). Potential confounding variables were identified through careful evaluation of risk factors for ESCC previously proposed to be important in the scientific literature ([@ref15], [@ref23]), together with our own background knowledge of this field. Missing data were disregarded when constructing the multivariate logistic regression models. In a separate analysis of ESCC in association with gastric atrophy, we also assessed the influence of missingness by using dummy variables indicating missing.

### Assessment of interactions. {#sec7}

We examined both potential multiplicative and additive interactions between gastric atrophy and poor oral health, alcohol consumption, cigarette smoking, and tea drinking. In the case of multiplicative interactions, a cross-product term was introduced into the regression model and the *P* value was derived from Wald test. To test additive interactions, we used the relative excess risk due to interaction (RERI), synergy index (S), and attributable proportion (AP) due to interaction, and calculations were performed using the spreadsheet developed by Andersson et al. ([@ref26]). Because alcohol consumption, cigarette smoking, and tea drinking were not common among our female subjects, we examined the interaction between these factors and gastric atrophy only among the men.

A 2-sided *P* value of less than 0.05 was considered statistically significant. All statistical analyses were carried out with SAS, version 9.4 (SAS Institute, Inc., Cary, North Carolina).

Sensitivity analysis {#sec8}
--------------------

Sensitivity analysis was attempted by restricting the analysis of combined effects of gastric atrophy and oral health to patients with a serum level of PGII of \<11.8 μg/L, as proposed in our earlier investigation in an area with a high incidence of ESCC ([@ref12]). To assess the potential influence of nondifferential misclassification, we also performed such an analysis only on cases identified by the endoscopy units.

Ethical considerations {#sec9}
----------------------

This study was approved by the Institutional Review Board of the School of Life Sciences, Fudan University; the Institutional Review Board of Qilu Hospital, Shandong University; and the Regional Vetting Board of Stockholm (Dnr 2018/357--31). All participants provided written informed consent.

RESULTS {#sec10}
=======

The ratio of men to women (2:1) among our cases is typical for areas with a high incidence of ESCC ([Table 1](#TB1){ref-type="table"}). Our frequency matching ensured that there were no differences in sex or age between the cases and controls. Although male cases and controls were similar in age, marital status, occupation, missing and filled teeth, and *H. pylori* serostatus, they did differ with regard to the other variables ([Table 1](#TB1){ref-type="table"}). Female cases and controls were similar in marital status, tea drinking, smoking, alcohol consumption, and *H. pylori* serostatus, but they differed in all other respects ([Table 1](#TB1){ref-type="table"}). The median PGI and PGII levels and PGI:PGII ratio differed statistically between male, but not female, cases and controls ([Table 2](#TB2){ref-type="table"}).

###### 

Demographic Information for Study Subjects Enrolled in a Case-Control Study of Esophageal Squamous Cell Carcinoma (*n* = 3,188), Taixing, China, 2010--2014

                                                                        **Men (*n* = 2,180)**                         **Women (*n* = 1,008)**                                                                                                                                            
  -------------------------------------------------------------------- ----------------------- ------------ -------------------------------------------- ------------ ------------ ------------------------------------------ -------------------------------------------- ----- ------- --
   Age at interview, years[^a^](#tblfn1){ref-type="table-fn"}                65.6 (8.4)         65.5 (8.5)    0.547[^b^](#tblfn2){ref-type="table-fn"}    67.6 (9.4)   69.5 (7.6)   0.016[^b^](#tblfn2){ref-type="table-fn"}                                                             
   Age group at interview, years                                                                              0.132[^c^](#tblfn3){ref-type="table-fn"}                                                                         \<0.001[^c^](#tblfn3){ref-type="table-fn"}                
    40--49                                                                       53                3.89                          25                          3.06                                      29                                         4.72                       5    1.27   
    50--59                                                                       274              20.10                         180                         22.03                                      89                                        14.47                      28    7.12   
    60--69                                                                       584              42.85                         352                         43.08                                     208                                        33.82                      162   41.22  
    70--79                                                                       402              29.49                         216                         26.44                                     235                                        38.21                      160   40.71  
    80--85                                                                       50                3.67                          44                          5.39                                      54                                         8.78                      38    9.67   
   Educational level                                                                                          0.003[^c^](#tblfn3){ref-type="table-fn"}                                                                         \<0.001[^d^](#tblfn4){ref-type="table-fn"}                
    Illiterate                                                                   171              12.55                         145                         17.75                                     366                                        59.51                      285   72.52  
    Primary school                                                               585              42.92                         357                         43.70                                     171                                        27.80                      91    23.16  
    Middle school                                                                459              33.68                         235                         28.76                                      66                                        10.73                      15    3.82   
    High school and above                                                        148              10.86                          80                          9.79                                      12                                         1.95                       2    0.51   
   Marital status                                                                                             0.574[^c^](#tblfn3){ref-type="table-fn"}                                                                          0.677[^d^](#tblfn4){ref-type="table-fn"}                 
    Unmarried                                                                    63                4.62                          41                          5.02                                      5                                          0.81                       2    0.51   
    Married                                                                     1,151             84.45                         676                         82.74                                     426                                        69.27                      264   67.18  
    Divorced/widowed                                                             149              10.93                         100                         12.24                                     184                                        29.92                      127   32.32  
   Occupation                                                                                                 0.494[^c^](#tblfn3){ref-type="table-fn"}                                                                          0.006[^c^](#tblfn3){ref-type="table-fn"}                 
    Farmer                                                                       709              52.02                         446                         54.59                                     545                                        88.62                      371   94.40  
    Worker                                                                       354              25.97                         198                         24.24                                      43                                         6.99                      16    4.07   
    Service/clerk/professional/administrator                                     300              22.01                         173                         21.18                                      27                                         4.39                       6    1.53   
   Family wealth score                                                                                       \<0.001[^c^](#tblfn3){ref-type="table-fn"}                                                                         0.011[^c^](#tblfn3){ref-type="table-fn"}                 
    Quintile 1 (lowest)                                                          288              21.13                         238                         29.13                                     119                                        19.35                      110   27.99  
    Quintile 2                                                                   231              16.95                         135                         16.52                                     119                                        19.35                      74    18.83  
    Quintile 3                                                                   285              20.91                         191                         23.38                                     144                                        23.41                      91    23.16  
    Quintile 4                                                                   295              21.64                         150                         18.36                                     130                                        21.14                      72    18.32  
    Quintile 5 (highest)                                                         264              19.37                         103                         12.61                                     103                                        16.75                      46    11.70  
   Body mass index[^e^](#tblfn5){ref-type="table-fn"} 10 years prior                                         \<0.001[^c^](#tblfn3){ref-type="table-fn"}                                                                         0.001[^c^](#tblfn3){ref-type="table-fn"}                 
    \<18.5                                                                       59                4.33                          63                          7.71                                      56                                         9.11                      52    13.23  
    18.5--23.9                                                                   857              62.88                         555                         67.93                                     340                                        55.28                      219   55.73  
    24.0--27.9                                                                   363              26.63                         166                         20.32                                     172                                        27.97                      112   28.50  
    ≥28.0                                                                        82                6.02                          30                          3.67                                      46                                         7.48                       9    2.29   
    Missing                                                                       2                0.15                          3                           0.37                                      1                                          0.16                       1    0.25   
   Sum of missing and filled teeth                                                                            0.121[^c^](#tblfn3){ref-type="table-fn"}                                                                          0.009[^c^](#tblfn3){ref-type="table-fn"}                 
    0                                                                            366              26.85                         193                         23.62                                     129                                        20.98                      55    13.99  
    1--3                                                                         349              25.61                         187                         22.89                                     137                                        22.28                      72    18.32  
    4--11                                                                        345              25.31                         211                         25.83                                     164                                        26.67                      107   27.23  
    ≥12                                                                          285              20.91                         197                         24.11                                     177                                        28.78                      140   35.62  
    Missing                                                                      18                1.32                          29                          3.55                                      8                                          1.30                      19    4.83   
   Frequency of toothbrushing per day                                                                        \<0.001[^c^](#tblfn3){ref-type="table-fn"}                                                                        \<0.001[^c^](#tblfn3){ref-type="table-fn"}                
    Once or less                                                                 896              65.74                         649                         79.44                                     385                                        62.60                      312   79.39  
    Twice or more                                                                449              32.94                         141                         17.26                                     223                                        36.26                      69    17.56  
    Missing                                                                      18                1.32                          27                          3.30                                      7                                          1.14                      12    3.05   
   Tea drinking                                                                                              \<0.001[^c^](#tblfn3){ref-type="table-fn"}                                                                         0.220[^c^](#tblfn3){ref-type="table-fn"}                 
    Never                                                                        852              62.51                         421                         51.53                                     574                                        93.33                      363   92.37  
    Ever                                                                         491              36.02                         358                         43.82                                      31                                         5.04                      13    3.31   
    Missing                                                                      20                1.47                          38                          4.65                                      10                                         1.63                      17    4.33   
   History of esophageal cancer among first-degree relatives                                                 \<0.001[^c^](#tblfn3){ref-type="table-fn"}                                                                        \<0.001[^c^](#tblfn3){ref-type="table-fn"}                
    No                                                                          1,098             80.56                         532                         65.12                                     496                                        80.65                      257   65.39  
    Yes                                                                          250              18.34                         256                         31.33                                     111                                        18.05                      122   31.04  
    Missing                                                                      15                1.10                          29                          3.55                                      8                                          1.30                      14    3.56   
   Smoking status[^f^](#tblfn5){ref-type="table-fn"}                                                         \<0.001[^c^](#tblfn3){ref-type="table-fn"}                                                                         0.841[^d^](#tblfn4){ref-type="table-fn"}                 
    Never-smoker                                                                 315              23.11                         171                         20.93                                     591                                        96.10                      374   95.17  
    Former-smoker                                                                152              11.15                          61                          7.47                                      4                                          0.65                       2    0.51   
    Current light smoker                                                         231              16.95                         104                         12.73                                      13                                         2.11                      10    2.54   
    Current medium smoker                                                        411              30.15                         262                         32.07                                      6                                          0.98                       5    1.27   
    Current heavy smoker                                                         253              18.56                         215                         26.32                                      1                                          0.16                       2    0.51   
    Missing                                                                       1                0.07                          4                           0.49                                      0                                          0.00                       0    0.00   
   Alcohol drinking status[^g^](#tblfn5){ref-type="table-fn"}                                                \<0.001[^c^](#tblfn3){ref-type="table-fn"}                                                                         0.425[^d^](#tblfn4){ref-type="table-fn"}                 
    Never drinker                                                                580              42.55                         191                         23.38                                     570                                        92.68                      348   88.55  
    Former drinker                                                               72                5.28                          34                          4.16                                      5                                          0.81                       2    0.51   
    Current low consumption                                                      159              11.60                         106                         12.97                                      18                                         2.93                      19    4.83   
    Current medium consumption                                                   361              26.49                         298                         36.47                                      9                                          1.46                       5    1.27   
    Current high consumption                                                     170              12.47                         150                         18.36                                      2                                          0.33                       0    0.00   
    Missing                                                                      21                1.54                          38                          4.65                                      11                                         1.79                      19    4.83   
  * Helicobacter pylori* serostatus                                                                           0.119[^c^](#tblfn3){ref-type="table-fn"}                                                                          0.848[^c^](#tblfn3){ref-type="table-fn"}                 
    Negative                                                                     448              32.87                         242                         29.62                                     187                                        30.41                      122   31.04  
    Positive                                                                     902              66.18                         566                         69.28                                     422                                        68.62                      268   68.19  
    Missing                                                                      13                0.95                          9                           1.10                                      6                                          0.98                       3    0.76   

^a^ Values are expressed as mean (standard deviation).

^b^ Mann-Whitney unpaired test for continuous variables was used to derive *P* values after excluding the corresponding missing value.

^c^ χ ^2^ test was used to derive *P* values after excluding the corresponding missing value.

^d^ Fisher exact test for categorical variables was used to derive *P* values after excluding the corresponding missing value.

^e^ Weight (kg)/height (m)^2^

^f^ Current smokers: light, ≤18 pack-years; medium, 19--40 pack-years; and heavy, ≥41 pack-years.

^g^ Current drinkers: low consumption, ≤40 g/day; medium consumption, 41--135 g/day; and high consumption, \>135 g/day.

###### 

Serum Pepsinogen Values for Enrollees in a Case-Control Study of Esophageal Squamous Cell Carcinoma (*n* = 3,188), Taixing, China, 2010--2014

  ------------------------------------------------------------------------------------------------------------------------------------
  **Sex and Group**   **No.**   **Missing**   **Mean**\     **Median**\       **Range**    **25th--75th Percentile**   
                                              **(SD)**       **(IQR)**                                                 
  ------------------- --------- ------------- ----------- ---------------- --------------- --------------------------- ---------------
  *PGI, μg/L*                                                                                                          

  Women                                                                                                                

   Cases              391       2             0.51         97.52 (75.31)    79.32 (65.23)  0.00--469.40                51.77--117.00

   Controls           611       4             0.65         92.94 (50.05)    84.48 (53.37)  0.00--350.40                60.43--113.80

  Men                                                                                                                  

   Cases              813       4             0.49         109.95 (84.29)   89.55 (77.84)  0.00--521.00                56.56--134.40

   Controls           1,350     13            0.95         104.08 (55.82)   95.74 (59.96)  0.00--487.80                69.34--129.30

  *PGII, μg/L*                                                                                                         

  Women                                                                                                                

   Cases              392       1             0.25         12.90 (13.81)    9.88 (12.06)   0.03--184.10                4.86--16.92

   Controls           611       4             0.65         13.78 (11.64)    10.04 (14.67)  0.05--105.70                5.16--19.85

  Men                                                                                                                  

   Cases              814       3             0.37         13.96 (15.09)    10.75 (11.87)  0.05--251.20                5.79--17.66

   Controls           1,352     11            0.81         14.76 (12.42)    12.12 (12.89)  0.05--244.00                6.94--19.83

  *PGI:PGII Ratio*                                                                                                     

  Women                                                                                                                

   Cases              391       2             0.51         32.42 (178.40)    8.54 (8.85)   0.00--2996.00               5.17--14.03

   Controls           611       4             0.65         33.56 (163.27)    8.10 (7.99)   0.00--2244.00               5.03--13.02

  Men                                                                                                                  

   Cases              813       4             0.49         39.55 (306.54)    8.87 (7.72)   0.00--6614.00               5.94--13.66

   Controls           1,349     14            1.03         26.08 (155.90)    7.93 (6.75)   0.00--2732.00               5.32--12.08
  ------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: IQR, interquartile range; PGI, pepsinogen I; PGII, pepsinogen II; SD, standard deviation.

The odds ratio for ESCC in association with gastric atrophy (defined as a PGI level of \<55 μg/L), when adjusted for age and sex, was 1.60 (95% confidence interval (CI): 1.34, 1.90) ([Table 3](#TB3){ref-type="table"}). The estimate was quite similar when fully adjusted for age, sex, education, marital status, occupation, family wealth score, body mass index 10 years before, tea drinking, history of esophageal cancer among first-degree relatives, smoking status, alcohol consumption, and *H. pylori* serostatus (odds ratio = 1.63, 95% CI: 1.35, 1.97), and even when adjusted further for the sum of missing and filled teeth and frequency of daily toothbrushing (odds ratio = 1.61, 95% CI: 1.33, 1.96) ([Table 3](#TB3){ref-type="table"}). Analyses stratified by sex showed statistically significant odds ratios for ESCC in association with gastric atrophy in both men and women (data not shown). In a subset of the cases for whom we had information about tumor location, the odds ratio for ESCC in the upper part of the esophagus was 1.35 (95% CI: 0.87, 2.09) while the odds ratio for ESCC in the mid and lower part of the esophagus was 1.87 (95% CI 1.50, 2.34). When other cutoff values were employed to define gastric atrophy, the resulting odds ratios were always greater than 1 but not always statistically significant (Web Table 2). *H. pylori* serostatus did not differ significantly between the cases and controls ([Table 3](#TB3){ref-type="table"}).

###### 

Odds Ratios for Esophageal Squamous Cell Carcinoma in Association With Gastric Atrophy, Defined by Pepsinogen I Values of \<55 μg/L, and *Helicobacter pylori* Seropositivity in a Case-Control Study, Taixing, China, 2010--2014

  **Variable**              **Controls**   **Cases**   **Age/Sex-Adjusted** [^**b**^](#tblfn9){ref-type="table-fn"}   **Fully Adjusted (Except MFT and Toothbrushing)** [^**c**^](#tblfn10){ref-type="table-fn"}   **Fully Adjusted** [^**d**^](#tblfn11){ref-type="table-fn"}                                                                    
  ------------------------- -------------- ----------- -------------------------------------------------------------- -------------------------------------------------------------------------------------------- ------------------------------------------------------------- ------------ -- --------- ------------ -- --------- ------------ --
   PGI, μg/L                                                                                                                                                                                                       \<0.001                                                                       \<0.001                   \<0.001                
   ≥55                      1,592          83.3        841                                                            75.1                                                                                         1.00                                                          Referent        1.00      Referent        1.00      Referent     
   \<55                     319            16.7        279                                                            24.9                                                                                         1.60                                                          1.34, 1.90      1.63      1.35, 1.97      1.61      1.33, 1.96   
  * H. pylori* serostatus                                                                                                                                                                                          0.215                                                                         0.211                     0.248                  
   Negative                 622            32.5        340                                                            30.3                                                                                         1.00                                                          Referent        1.00      Referent        1.00      Referent     
   Positive                 1,291          67.5        782                                                            69.7                                                                                         1.10                                                          0.95, 1.29      1.11      0.94, 1.32      1.11      0.93, 1.31   

Abbreviations: CI, confidence interval; MFT, missing and filled teeth; OR, odds ratio; PGI, pepsinogen I.

^a^ Complete observations in the full model.

^b^ Adjusted for age (continuous) and sex.

^c^ Adjusted for age (continuous), sex, education, marital status, occupation, family wealth score, body mass index 10 years prior, tea drinking, history of esophageal cancer among first-degree relatives, smoking status, alcohol drinking status, and *H. pylori* serostatus (except age, all other variables are categorized as in [Table 1](#TB1){ref-type="table"}).

^d^ Additionally adjusted for sum of missing and filled teeth and frequency of toothbrushing per day.

When gastric atrophy was defined as a serum level of PGI of \<55 μg/L, none of the multiplicative interactions between gastric atrophy and missing and filled teeth or number of daily toothbrushings were statistically significant ([Table 4](#TB4){ref-type="table"}). However, indicators of additive interaction---the relative excess risk due to interaction, synergy index, and attributable proportion due to interaction---were all significant in the case of toothbrushing. When gastric atrophy was defined as a PGI of \<30 μg/L, the relative excess risk due to interaction was 1.17, the synergy index was 2.38, and the attributable proportion due to interaction was 0.39 for the sum of missing and filled teeth, with corresponding values of 2.40, 2.95, and 0.52 for toothbrushing (Web Table 3). Sensitivity analysis limited to those with PGII \< 11.8 μg/L produced similar results (Web Table 4). No significant positive interactions between gastric atrophy (defined as PGI \< 55 μg/L) and alcohol consumption, cigarette smoking, or tea drinking were observed (Web Table 5). Sensitivity analysis restricted to cases identified by endoscopy units did not change the results materially (data not shown). Including subjects with missing data in the multivariate logistic regression model also did not change the estimates markedly (data not shown).

DISCUSSION {#sec11}
==========

Previous reports on the potential association between gastric atrophy and ESCC have been inconsistent, probably due to inappropriate study design and small sample sizes in some studies. Although a prospective cohort study on patients diagnosed histopathologically with gastric atrophy would be ideal, such a study is almost impossible to perform because of ethical considerations and the relatively low incidence of ESCC. A population-based case-control study with a large sample size would be the next best choice, but again, endoscopic examination of all cases and control subjects is not possible. Although gastric atrophy defined serologically is an inherent limitation due to the poor sensitivity of pepsinogen biomarkers, such nondifferential misclassification would bias the true association towards null. Thus, our present population-based, case-control study, with a large sample size, would provide a good possibility of detecting any potential blurred association and any interactions with other risk factors.

Our findings confirm that gastric atrophy (defined as a PGI serum level of \<55 μg/L) is a risk factor for ESCC in a high-risk region in eastern China, even after adjusting for a variety of known potential confounders. The cutoff point of \<55 μg/L was validated with the same test system (Pepsinogen I and II Kits; Biohit HealthCare) in a prior study in northern Iran with similar prevalence of *H. pylori* infection and pangastritis as well as ESCC incidence and mortality as in this study.

Our conclusion is contradictory to that arrived at on the basis of a case-cohort study in another high-risk area in China ([@ref9]). However, with a similar cutoff value of ≤50 μg/L for PGI, the point estimate of 1.64 (hazard ratio) in that earlier investigation (although only borderline statistically significant due to the small sample size) is very close to our estimate here.

However, their nonlinear continuous model, using the median of the 4th quartile of PGI:PGII ratio as a reference, showed no obvious trend. Here, we also found that the median PGI:PGII ratio was higher among cases than controls. Smoking ([@ref27]) and use of proton pump inhibitors ([@ref28]) (probably more common among cases than controls), might raise PGI levels and explain this difference. Moreover, because the biological meaning of a high PGI level or PGI:PGII ratio remains unclear, the usefulness of treating these as continuous variables is uncertain.

###### 

Estimation of Combined Effects of Gastric Atrophy (Defined by Pepsinogen I Values of \< 55 μg/L), Dental Health, and Oral Hygiene on Esophageal Squamous Cell Carcinoma Risk in a Case-Control Study in Taixing, China, 2010--2014

                                                                       **No Gastric Atrophy**   **Gastric Atrophy Present**   **Interaction Analysis**                                                                                                              
  -------------------------------------------------------------------- ------------------------ ----------------------------- -------------------------- ------------ ----- ----- ------ ------------ ------ ------------- ------ ------------ ------ ------------- -------
   Missing and filled teeth[^d^](#tblfn15){ref-type="table-fn"}                                                                                                                                                                                                     
    \<4                                                                824                      388                           1.00                       Referent     143   105   1.66   1.23, 2.25                                                                 
    ≥4                                                                 768                      453                           1.55                       1.18, 2.03   176   174   2.45   1.76, 3.93   0.23   −0.53, 0.99   1.19   0.67, 2.10   0.09   −0.20, 0.39   0.786
   No. of toothbrushings per day[^e^](#tblfn16){ref-type="table-fn"}                                                                                                                                                                                                
    ≥2                                                                 545                      158                           1.00                       Referent     106   44    1.27   0.84, 1.93                                                                 
    ≤1                                                                 1,047                    683                           2.14                       1.72, 2.65   213   235   3.67   2.80, 4.85   1.28   0.39, 2.18    1.91   1.16, 3.15   0.35   0.15, 0.55    0.203

Abbreviations: AP, attributable proportion; CI, confidence interval; OR, odds ratio; RERI~OR~, relative excess risk due to interaction; S, synergy index.

^a^ Complete observations.

^b^ All ORs were adjusted for age (continuous), sex, education, marital status, occupation, family wealth score, body mass index 10 years prior, tea drinking, history of esophageal cancer among first-degree relatives, smoking status, alcohol drinking status, *Helicobacter pylori* serostatus (except age, all other variables are categorized as in [Table 1](#TB1){ref-type="table"}).

^c^ Attributable proportion due to interaction.

^d^ Additionally adjusted for frequency of toothbrushing per day.

^e^ Additionally adjusted for sum of missing and filled teeth.

A key limitation to the present investigation is the risk of misclassification of exposure, because gastric atrophy was measured by serum pepsinogen levels and not endoscopy. Due to the population-based study design, we did not ask healthy control subjects to undergo endoscopy for ethical reasons and logistics constraints, and therefore we did not collect the histopathological reports from gastric biopsies taken for clinical purposes from ESCC patients either, although they could have been used for histopathological confirmation of gastric atrophy in a subset of the ESCC patients. We attempted to minimize this limitation by considering a broad span of cutoff values for serum levels of PGI and/or the PGI:PGII ratio. Many cutoff values proposed previously showed robust indications that gastric atrophy is a risk factor for ESCC.

Even though we made considerable efforts to reduce the risk of bias and confounding here, this risk always remains. Although the age and sex distributions of respondents and nonrespondents were similar (Web Table 1), these groups might have differed with respect to other demographic, clinical, or social characteristics. If such differences were similar for the cases and controls, the results would be biased towards null, but a differential difference could distort the findings in an unknown manner. However, such differences would have to be of a magnitude that we do not consider reasonable. The situation is similar for other forms of information bias, such as misclassification of diagnosis. The 208 cases that were unavailable for analysis were similar to the 1,210 cases who provided a blood sample for analysis in most aspects, except for age, BMI, missing and filled teeth, and frequency of toothbrushing (Web Table 6). If all of them did not have gastric atrophy, our estimate would be deflated to a maximally adjusted odds ratio of 1.28 (95% CI: 1.06, 1.55), which is still statistically significant. If however all of them had gastric atrophy, that would increase our estimate to a maximally adjusted odds ratio of 2.73 (95% CI: 2.30, 3.25).

The generalizability of our study results might be limited due to the fact that our study population has one of the highest incidence rates of ESCC in the world. Another limitation is lack of oral health information regarding medical conditions such as untreated decay, tooth bleeding, leukoplakia, and gingivitis, which are closely related to the risk of ESCC.

The major strengths of this investigation are its truly population-based, case-control study design and our considerable efforts to minimize the influence of selection bias and recall bias. We collected detailed information concerning potential confounding factors. Furthermore, our large sample size guaranteed sufficient statistical power to detect even small effects and examine interactions.

Our overall interpretation of present and previous findings is that gastric atrophy appears to be a risk factor for ESCC, although the evidence is not yet definitive. The 2 possible underlying causal relationships proposed previously require further elucidation. First, oxidative damage caused by nonacidic gastroesophageal reflux ([@ref16]) might lead to malignant transformation of epithelial cells as it did in an animal model ([@ref29]). This is partly supported by a higher odds ratio for ESCC in the mid and lower part compared with that in the upper part of the esophagus in our study. Second, alterations in the gastric microbiota might be involved, given that we have detected dysbiosis among patients with ESCC and squamous dysplasia ([@ref30]). The altered gastric microbiome might harbor species that can carry out *N*-nitrosation, producing substances known to be carcinogenic towards esophageal mucosa ([@ref16]).

We also found an additive interaction with poor oral hygiene, which might be due to a biological interaction mechanism. Again, altered microbiota in the oral cavity, due to poor dental health and oral hygiene, might lead to distant effects from inflammation ([@ref10]) or enhanced production of carcinogenic nitrosamines ([@ref11], [@ref31]). Furthermore, gastric atrophy might act as a source of such altered microbiota ([@ref12]). Another explanation for our observed findings could be that the microbiome associated with poor oral health could predispose the development of gastric atrophy and subsequent carcinogenesis in susceptible individuals, and if so, gastric atrophy might lie in the pathway between poor oral health and ESCC. However poor oral health might also be a confounder for the association between gastric corpus atrophy and ESCC. Altogether, we recommend that future research in this area employ histopathological diagnosis of gastric atrophy and explore the role of an altered gastric and oral microbiome in the development of ESCC ([@ref30]).

In summary, we conclude that gastric atrophy (as defined by the serum level of pepsinogen), appears to be a risk factor for ESCC in a high-risk region of eastern China, and furthermore, there are indications of an additive interaction with poor oral hygiene.

Supplementary Material
======================
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Click here for additional data file.
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